RxDoctor Payments Data

Nicole Lyons

Psychiatric/Mental Health · Gilbert, AZNPI 1093121600

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,654 of the $7,149 with a category attached, or 79.1%. It is spread thinly across 15 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,286, more than ten times the $277 reported in 2021. Among psychiatric/mental health clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,149in general payments, 2019–2025

Across 225 payments — averaging $31.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neuronetics, Inc.$2K
  • AbbVie$1K
  • Alkermes, Inc.$987
  • Neurocrine Biosciences, Inc.$735
  • Johnson & Johnson$682
  • Teva Pharmaceuticals USA, Inc.$591
  • plus $1K from 9 others

What the payments were for

  • Travel & lodging$1,39019%
  • Food & beverage$5,65479%
  • Education$1041%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,149 in reported general payments places this provider in the 95th percentile of 1,230 psychiatric/mental health providers in Arizona.

See all psychiatric/mental health providers in Arizona

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate39$109,512
SpravatoEsketamine Hcl24$28,720
OzempicSemaglutide12$20,150
LinzessLinaclotide29$16,717
Lurasidone Hcl18$6,200
Advair HfaFluticasone Propion/Salmeterol13$4,335
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine27$2,059
Bupropion XlBupropion Hcl51$2,034
Levothyroxine Sodium123$1,344
Gabapentin71$1,291
Ezetimibe-SimvastatinEzetimibe/Simvastatin11$1,246
Albuterol Sulfate HfaAlbuterol Sulfate46$1,228
Quetiapine Fumarate68$1,157
Divalproex Sodium ErDivalproex Sodium16$1,088
Pantoprazole Sodium47$819

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Spravato$682$138,23263 claims
AbbVieLinzess$1,117$16,71729 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,230 psychiatric/mental health providers in Arizona.

Other psychiatric/mental health in Gilbert

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →